Showing 3 of 3 recruiting trials for “familial-dysfibrinogenemia”
A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer
👨⚕️ Emmanuelle SAMALIN, MD, Institut du Cancer de Montepllier📍 21 sites📅 Started Mar 2025View details ↗
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →